| Record ID | marc_records_scriblio_net/part17.dat:71237663:1237 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part17.dat:71237663:1237?format=raw |
LEADER: 01237cam 2200313 a 4500
001 84045600 //r85
003 DLC
005 19850909000000.0
008 840919s1984 enka b 10100 eng d
010 $a 84045600 //r85
020 $a0126916608 (alk. paper)
040 $aDNLM/DLC$cDLC
050 0 $aQP603.M6$bM65 1984
060 $aQV 77.5 M7504 1983
082 0 $a574.19/258$219
245 00 $aMonoamine oxidase and disease :$bprospects for therapy with reversible inhibitors /$cedited by K.F. Tipton, P. Dostert, and M. Strolin Benedetti.
260 0 $aLondon ;$aOrlando, Fla. :$bAcademic Press,$c1984.
300 $axxxiii, 694 p. :$bill. ;$c24 cm.
500 $a"Based on the proceedings of a conference held 26-28 October 1983 in Paris, France"--P. [ii].
500 $aOrganized by the Centre de recherche Delalande.
504 $aIncludes bibliographies and indexes.
650 0 $aMonoamine oxidase$xCongresses.
650 0 $aMonoamine oxidase$xInhibitors$xTherapeutic use$xCongresses.
650 2 $aMonoamine Oxidase$xcongresses.
650 2 $aMonoamine Oxidase Inhibitors$xcongresses.
700 10 $aTipton, Keith F.
700 10 $aDostert, P.
700 20 $aStrolin Benedetti, M.
710 20 $aCentre de recherche Delalande.